BioVenic

BioVenic is a biotechnology company that provides research and development solutions for the animal health, breeding, and nutrition sectors. The company operates advanced technology platforms that support multi-species research, including companion animals, livestock, poultry, and aquatic species. Their capabilities encompass animal molecular breeding, genetics, veterinary therapy development, and metabolic research. BioVenic offers a comprehensive portfolio of research products, such as animal-derived reagents, serum, plasma, antibodies, and enzymes, alongside specialized services like genetic testing, DNA preservation, and reproductive technology support. By integrating sequencing and multi-omics analysis with gene editing and bioinformatics, they provide one-stop R&D solutions designed to improve animal productivity, health, and welfare.

These services and products are essential for researchers, veterinary biopharmaceutical companies, and agricultural industries looking to accelerate their development cycles. By providing reliable reagents and specialized technical expertise, BioVenic assists partners in streamlining transitions from initial research to assay validation. Their focus on high-quality standards and innovative genomic platforms enables customers to address complex challenges in animal agriculture and veterinary medicine, facilitating advancements in animal health and sustainability. The company serves a global client base through its research facilities and distribution network, supporting both commercial industrial applications and academic research projects.